124 related articles for article (PubMed ID: 21697613)
1. Absence of excretion of the active moiety of bisacodyl and sodium picosulfate into human breast milk: an open-label, parallel-group, multiple-dose study in healthy lactating women.
Friedrich C; Richter E; Trommeshauser D; de Kruif S; van Iersel T; Mandel K; Gessner U
Drug Metab Pharmacokinet; 2011; 26(5):458-64. PubMed ID: 21697613
[TBL] [Abstract][Full Text] [Related]
2. bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM)-the active metabolite of the laxatives bisacodyl and sodium picosulfate-enhances contractility and secretion in human intestine in vitro.
Krueger D; Demir IE; Ceyhan GO; Zeller F; Schemann M
Neurogastroenterol Motil; 2018 Jul; 30(7):e13311. PubMed ID: 29441646
[TBL] [Abstract][Full Text] [Related]
3. Bis-(p-hydroxyphenyl)-pyridyl-2-methane: The common laxative principle of Bisacodyl and sodium picosulfate.
Jauch R; Hankwitz R; Beschke K; Pelzer H
Arzneimittelforschung; 1975 Nov; 25(11):1796-1800. PubMed ID: 1243088
[TBL] [Abstract][Full Text] [Related]
4. Is bisacodyl absorbed at all from suppositories in man?
Flig E; Hermann TW; Zabel M
Int J Pharm; 2000 Feb; 196(1):11-20. PubMed ID: 10675703
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity liquid chromatography-tandem mass spectrometry method for the simultaneous determination of sodium picosulfate and its three major metabolites in human plasma.
Yang Y; Yu J; Lu Y; Xia Y; Zhong D; Chen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 915-916():1-7. PubMed ID: 23314398
[TBL] [Abstract][Full Text] [Related]
6. The role of intestinal bacteria in the transformation of sodium picosulfate.
Kim DH; Hyun SH; Shim SB; Kobashi K
Jpn J Pharmacol; 1992 May; 59(1):1-5. PubMed ID: 1507649
[TBL] [Abstract][Full Text] [Related]
7. Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.
Mueller-Lissner S; Kamm MA; Wald A; Hinkel U; Koehler U; Richter E; Bubeck J
Am J Gastroenterol; 2010 Apr; 105(4):897-903. PubMed ID: 20179697
[TBL] [Abstract][Full Text] [Related]
8. A sensitive and quantitative immunochromatographic assay for simultaneous detection of three stimulant laxatives in slimming food.
Chen S; Guan T; Qian Z; Quan Q; Wang J; Li X; Wu S; Yan Y; Yao X; Zhang S; Lei H
Food Chem; 2023 Jan; 398():133861. PubMed ID: 35973297
[TBL] [Abstract][Full Text] [Related]
9. Enterohepatic circulation, urinary excretion and laxative action of some bisacodyl derivatives after intragastric administration in the rat.
Sund RB; Songedal K; Harestad T; Salvesen B; Kristiansen S
Acta Pharmacol Toxicol (Copenh); 1981 Jan; 48(1):73-80. PubMed ID: 7223440
[TBL] [Abstract][Full Text] [Related]
10. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics and laxative effect of bisacodyl following administration of various dosage forms].
Roth W; Beschke K
Arzneimittelforschung; 1988 Apr; 38(4):570-4. PubMed ID: 3401271
[TBL] [Abstract][Full Text] [Related]
12. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation.
Kienzle-Horn S; Vix JM; Schuijt C; Peil H; Jordan CC; Kamm MA
Curr Med Res Opin; 2007 Apr; 23(4):691-9. PubMed ID: 17407625
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Sodium Picosulfate/Magnesium Citrate for Bowel Preparation in a Physically Disabled Outpatient Population: A Randomized, Endoscopist-Blinded Comparison With Ascorbic Acid-Enriched Polyethylene Glycol Solution Plus Bisacodyl (The PICO-MOVI Study).
Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS
Dis Colon Rectum; 2018 Feb; 61(2):239-249. PubMed ID: 29337780
[TBL] [Abstract][Full Text] [Related]
14. Effects of sodium picosulfate, bisacodyl and sennoside in cultured human, rat and rabbit liver cells.
Nishikawa J; Kast A
Arzneimittelforschung; 1981; 31(6):1010-3. PubMed ID: 7196230
[TBL] [Abstract][Full Text] [Related]
15. Split-dose bowel cleansing with picosulphate is safe and better tolerated than 2-l polyethylene glycol solution.
Mathus-Vliegen EMH; van der Vliet K; Wignand-van der Storm IJ; Stadwijk JS
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):709-717. PubMed ID: 29642094
[TBL] [Abstract][Full Text] [Related]
16. Bisacodyl: A review of pharmacology and clinical evidence to guide use in clinical practice in patients with constipation.
Corsetti M; Landes S; Lange R
Neurogastroenterol Motil; 2021 Oct; 33(10):e14123. PubMed ID: 33751780
[TBL] [Abstract][Full Text] [Related]
17. Lemborexant levels in breast milk after single doses in healthy, lactating women.
Rawal S; Brimhall D; Aluri J; Cheng JY; Hall N; Moline M
Br J Clin Pharmacol; 2024 Jan; 90(1):158-163. PubMed ID: 37565541
[TBL] [Abstract][Full Text] [Related]
18. Screening procedure for detection of stimulant laxatives and/or their metabolites in human urine using gas chromatography-mass spectrometry after enzymatic cleavage of conjugates and extractive methylation.
Beyer J; Peters FT; Maurer HH
Ther Drug Monit; 2005 Apr; 27(2):151-7. PubMed ID: 15795644
[TBL] [Abstract][Full Text] [Related]
19. Review: Prucalopride, velusetrag, bisacodyl, and sodium picosulfate improve chronic idiopathic constipation.
Nee J; Feuerstein JD
Ann Intern Med; 2016 Oct; 165(8):JC41. PubMed ID: 27750301
[No Abstract] [Full Text] [Related]
20. Excretion of moxidectin into breast milk and pharmacokinetics in healthy lactating women.
Korth-Bradley JM; Parks V; Chalon S; Gourley I; Matschke K; Gossart S; Bryson P; Fleckenstein L
Antimicrob Agents Chemother; 2011 Nov; 55(11):5200-4. PubMed ID: 21896908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
